Cargando…
Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19
Autores principales: | Yang, Geliang, Zhang, Huiqing, Yang, Yufei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079301/ https://www.ncbi.nlm.nih.gov/pubmed/32178547 http://dx.doi.org/10.1177/1534735420912811 |
Ejemplares similares
-
The Challenge and Management of Clinical Trials in Integrative Cancer during
the COVID-19 Pandemic Worldwide
por: Yang, Geliang, et al.
Publicado: (2021) -
Challenges for Obstetricians and the Countermeasures of COVID-19 Epidemic
por: Zhao, Yin, et al.
Publicado: (2020) -
Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19
por: Guo, Haoyue, et al.
Publicado: (2020) -
Revisiting Japan's early COVID‐19 countermeasures
por: Kaneda, Yudai, et al.
Publicado: (2023) -
Response to “Characteristic Analysis of Complementary and Alternative Medicine in Randomized Controlled Trials of Oncology: A Comparison of Published Studies”
por: Yang, Geliang, et al.
Publicado: (2019)